Board of Directors
The Board of Directors is composed of the following accomplished and experienced members;
David began his career in 1987 in investment banking, working in corporate finance roles for Credit Suisse First Boston, UBS and Lehman Brothers. In 2003 he moved to WhatIf Ventures, the investment arm of the innovation company WhatIf, where he specialised in commercialising new products and technologies in markets including UK annuities, high street retail, fast food and innovative polymers.
Prior to becoming CEO at Byotrol plc, David ran Byotrol Consumer Products (BCP) from its inception in 2007 within his partnership role at WhatIf Ventures, moving to full time early 2012. He led BCP to profitability in 2011 and then to the full acquisition by Byotrol plc in October 2013.
David has an MBA from London Business School and a BA from Oxford University.
Trevor’s career at Unilever spanned 29 years, initially in Manufacturing and that included 3 years as Production Director in Cote D’Ivoire, The second half of Trevor’s career at Unilever was spent in a number of Research and Development roles that culminated as Global VP R & D Homecare in 2001.
During Trevor’s period in R & D, he managed teams that brought a number of successful innovations to the market place. Trevor was also a principal driver in developing a progressive approach to Fragrance Management. After Unilever, Trevor established a management consultancy business, working with a number of consumer and chemical companies, before starting work as a consultant with Byotrol Consumer Products (BCP) not long after its inception.
Trevor is a graduate in Applied Chemistry of Queen’s University, Belfast and following completion of his Ph.D. at Queen’s he worked under Professor Zahn as a Post-Doctoral Fellow at DWI Aachen, Germany.
Nic qualified as a chartered accountant with KPMG, and then moved into investment banking, advising small and midcap companies in a broad range of transactions, including IPOs and other fund-raisings, public takeovers and private company sales and acquisitions. He held senior roles at UBS and HSBC. Latterly he was Head of M&A at N+1 Singer where he gained extensive experience in the AIM market.
He left corporate finance in 2017 and joined telecoms software company Pelatro as Finance Director, and led the finance team for its IPO in December 2017 and also the acquisition of the Danateq business in 2018.
Nic has a B.Sc. in Geography and Geology from Kings College London and is also a non-executive director at Defenx plc.
John is a Chartered Accountant and has been involved with listed businesses for over 30 years.
He was Chief Executive of British Polythene Industries PLC, the largest producer of polythene film products in Europe, with sales of more than £500 million, 2,350 employees and 21 manufacturing sites in the UK, Belgium, Holland, Canada and China, from 2003 until its sale to RPC in August 2016.
Between 1994 and 2002 he was Group Finance Director of BPI and was involved in the successful defence of a cash hostile takeover bid. In March 2002, he was awarded the Bank of Scotland’s Scottish Finance Director of the Year Award, which was a great achievement for both John and his team.
Prior to joining BPI he was Finance Director of Eclipse Blinds plc with sales of £40m. He was part of a turnaround team which successfully restructured the group and sold it to Headlam Group Plc, remaining as a Non-executive Director until the sale in 1997.
John’s career history also includes Finance Director at Scottish Enterprise, working with a £450m budget, and Finance Director of United Wire Group plc, which was subsequently acquired by Scapa Group.
John attended Forfar Academy and Dundee University where he attained an LLB before qualifying as a CA in 1976 with KPMG.
Till was formerly Senior Vice President for Corporate Strategy at AstraZeneca Plc and prior to that had a long and distinguished career with Zeneca Plc and ICI Pharmaceuticals, directing business and marketing operations internationally and overseeing the launch of several global blockbuster products.
He is a past President of the Association of the British Pharmaceutical Industry and has many years international industry experience, serving on the Boards of both the European and the International Pharmaceutical Industry Federations. He has also served on the Board of the Chemical Industries Association.
His business career has spanned research and development, territorial and marketing management, strategic planning, business operations, licensing and acquisitions/divestments, and public and government affairs. He has also acted as a corporate consultant to a number of high-tech companies within the US and the UK.
He is Chairman of Antikor Biopharma Limited and a Non-executive Director of Datapharm Communications Ltd and Helperby Therapeutics Group Limited.
He has a Doctorate in Chemistry from Oxford University.
Sean spent 20 years of his career at Unilever, where his roles included Global Divisional CEO of Unilever Baking, Cooking and Spreads, and Global Category EVP for Household Care. In the latter role, he led the rapid growth of a number of well-known household brands, including Domestos, Cif, Lysoform and Sunlight, from a sales value of €800m to over €2.5bn.
Sean also has a strong track record of advising a range of leading private equity firms and companies on the development of business strategies, brand portfolio plans, organisational structures and supply chain strategies.
He also acts as a Non‐executive Director at Slicethepie Ltd.
Sean has a BSc in Economics from University College London.